Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,866 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The influences of method of calcium correction and the timing of blood collection on application of the K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Japan.
Yokoyama K, Katoh N, Kasai K, Kubo H, Murai S, Shoji R, Imamura N, Saika S, Yumita S, Ishida M, Takasu S, Kono T, Yoshida Y, Wakabayashi T, Kimua Y, Hosoya T. Yokoyama K, et al. Among authors: yoshida y. Ther Apher Dial. 2006 Jun;10(3):257-61. doi: 10.1111/j.1744-9987.2006.00333.x. Ther Apher Dial. 2006. PMID: 16817790
Correlation between Efficacy and Cardiovascular Adverse Events in Patients with Advanced Solid Cancer Who Received VEGF Pathway Inhibitors: Hypertension within the First Eight Weeks is Associated with Favorable Outcomes of Patients Treated with VEGF Pathway Inhibitors.
Yoshida Y, Takahashi M, Komine K, Taniguchi S, Yamada H, Sasaki K, Umegaki S, Kawamura Y, Kasahara Y, Ouchi K, Imai H, Saijo K, Shirota H, Takenaga N, Ishioka C. Yoshida Y, et al. Intern Med. 2024 Jun 13. doi: 10.2169/internalmedicine.3373-23. Online ahead of print. Intern Med. 2024. PMID: 38866528 Free article.
Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations.
Kaneko S, Takasawa K, Asada K, Shiraishi K, Ikawa N, Machino H, Shinkai N, Matsuda M, Masuda M, Adachi S, Takahashi S, Kobayashi K, Kouno N, Bolatkan A, Komatsu M, Yamada M, Miyake M, Watanabe H, Tateishi A, Mizuno T, Okubo Y, Mukai M, Yoshida T, Yoshida Y, Horinouchi H, Watanabe SI, Ohe Y, Yatabe Y, Saloura V, Kohno T, Hamamoto R. Kaneko S, et al. Among authors: yoshida y. Mol Cancer. 2024 Jun 11;23(1):126. doi: 10.1186/s12943-024-02035-6. Mol Cancer. 2024. PMID: 38862995 Free PMC article.
Genome-wide DNA methylation status is a predictor of the efficacy of anti-EGFR antibodies in the second-line treatment of metastatic colorectal cancer: Translational research of the EPIC trial.
Ouchi K, Takahashi S, Sasaki K, Yoshida Y, Taniguchi S, Kasahara Y, Komine K, Imai H, Saijo K, Shirota H, Takahashi M, Ishioka C. Ouchi K, et al. Among authors: yoshida y. Int J Colorectal Dis. 2024 Jun 11;39(1):89. doi: 10.1007/s00384-024-04659-y. Int J Colorectal Dis. 2024. PMID: 38862615 Free PMC article.
6,866 results